Crellin Dianne J, Babl Franz E, Santamaria Nick, Harrison Denise
Department of Nursing, The University of Melbourne, Melbourne, Australia; Murdoch Children's Research Institute, Melbourne, Australia; Royal Children's Hospital, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia; Royal Children's Hospital, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
J Pediatr Nurs. 2018 May-Jun;40:14-26. doi: 10.1016/j.pedn.2018.02.005. Epub 2018 Feb 16.
Clinicians and researchers require a valid way to assess procedural pain experienced by infants and children. The Modified Behavioral Pain Scale (MBPS) has been used to assess immunisation pain. However, it is unknown whether it is valid for this purpose and whether use can be extended to other procedures. The aim of this study was to rigorously assess evidence addressing the psychometric properties of this scale and to provide recommendations for its use.
Psychometric evaluation studies reporting feasibility, reliability, validity, or utility data for the MBPS applied to children (birth to 18years) and randomised controlled trials (RCT) using the MBPS were included.
Twenty-eight studies (8 psychometric and 20 RCTs) were included.
Studies were of varying quality. Sufficient data was available to cautiously accept the MBPS as valid for assessing immunisation related pain in infants aged 2 to 22months. There was insufficient data to support the psychometrics in other age groups or in circumstances other than immunisation. There is no data addressing the clinical utility of the MBPS.
It is not possible at this time to confidently accept the MBPS as suitable for assessing all procedural pain in young children.
Studies to evaluate the capacity of the MBPS to assess pain in a range of procedures and to distinguish between pain and non-pain related distress are needed if it is to be recommended.
临床医生和研究人员需要一种有效的方法来评估婴幼儿所经历的操作疼痛。改良行为疼痛量表（MBPS）已被用于评估免疫接种疼痛。然而，尚不清楚该量表用于此目的是否有效，以及其使用范围能否扩展到其他操作。本研究的目的是严格评估关于该量表心理测量特性的证据，并为其使用提供建议。
纳入报告应用于儿童（出生至18岁）的MBPS的可行性、可靠性、有效性或实用性数据的心理测量评估研究，以及使用MBPS的随机对照试验（RCT）。
纳入了28项研究（8项心理测量研究和20项RCT）。
研究质量参差不齐。有足够的数据可以谨慎地接受MBPS对评估2至22个月大婴儿的免疫接种相关疼痛是有效的。没有足够的数据支持该量表在其他年龄组或免疫接种以外的情况下的心理测量学特性。没有关于MBPS临床实用性的数据。
目前无法自信地接受MBPS适用于评估幼儿的所有操作疼痛。
如果要推荐使用MBPS，需要开展研究来评估其在一系列操作中评估疼痛以及区分疼痛与非疼痛相关痛苦的能力。
